BBIO
BBIO
NASDAQ · Biotechnology

Bridgebio Pharma Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$67.39
-0.06 (-0.09%)
As of May 9, 1:08 AM ET ·
Analyst Consensus
Strong Buy
28
Analysts
High
Coverage
Buy 27 96%
Hold 1 4%
Sell 0 0%
Price Target
Analyst Price Target +182.0% upside
Low Target $141.92
Average Target $190.06
High Target $243.96
Current Price $67.39
Current
$67.39
Target
$190.06
$141.92 $190.06 avg $243.96
Scenario Analysis
Bear Case
$141.92
110.6%
Low target
Base Case
$190.06
+182.0%
Avg target
Bull Case
$243.96
+262.0%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$84.94
-20.7% from high
52-Week Low
$31.77
+112.1% from low
50-Day SMA
$75.38
-10.6% vs SMA
200-Day SMA
$56.39
+19.5% vs SMA
RSI (14)
38.4
Neutral
Target vs 52W High
$190.06
+123.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%